Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CBM:US

41.1000 USD 0.1400 0.34%

As of 15:10:42 ET on 05/22/2015.

Snapshot for Cambrex Corp (CBM)

Open: 41.2400 Day's Range: 40.7100 - 41.2799 Volume: 208,323
Previous Close: 41.2400 52wk Range: 15.7601 - 44.2200 1-Yr Rtn: +97.79%

Stock Chart for CBM

No chart data available.
  • CBM:US 41.1000
  • 1D
  • 1M
  • 1Y
41.2400
Interactive CBM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CBM

Current P/E Ratio (ttm) 77.1845
Estimated P/E(12/2015) 23.1960
Relative P/E vs. SPX 4.1288
Earnings Per Share (USD) (ttm) 0.5287
Est. EPS (USD) (12/2015) 1.7600
Est. PEG Ratio 1.5464
Market Cap (M USD) 1,277.78
Shares Outstanding (M) 31.31
30 Day Average Volume 489,466
Price/Book (mrq) 5.2697
Price/Sale (ttm) 3.2925
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 14.0000
Dividend Ex-Date 05/04/2007
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CBM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CBM

Cambrex Corp. supplies products, services, and technologies for the Life Sciences and fine chemicals industry. The Company builds platforms for use in manufacturing small molecule Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates including drug delivery. Cambrex's services include process & analytical development, scale-up in addition to generic APIs.

Steven M Klosk "Steve"President/CEOGregory P SargenExec VP/CFO
Shawn P CavanaghExec VP/COOSamantha M HanleyVP/Secretary/General Counsel
More Company Profile & Key Executives for CBM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil